Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma. [electronic resource]
Producer: 20120619Description: 490-5 p. digitalISSN:- 1096-8652
- Administration, Oral
- Aged
- Bone Density Conservation Agents -- administration & dosage
- Databases, Factual
- Diphosphonates -- administration & dosage
- Drug Utilization
- Female
- Fractures, Spontaneous -- epidemiology
- Humans
- Imidazoles -- administration & dosage
- Incidence
- Infusions, Intravenous
- International Classification of Diseases
- Male
- Medication Adherence
- Middle Aged
- Multiple Myeloma -- complications
- Osteolysis -- epidemiology
- Retrospective Studies
- Treatment Outcome
- United States -- epidemiology
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.